Banca Mediolanum Spa BANCA MEDIOL.../ IT0004776628 /
| 24/05/2024 17:29:50 | Chg. - | Volume | Bid17:40:13 | Ask17:40:13 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 10.58EUR | - | 328,856 Turnover: 3.29 mill. |
-Bid Size: - | -Ask Size: - | 7.96 bill.EUR | - | 9.63 |
GlobeNewswire
03/06
Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascula...
GlobeNewswire
07/02
The University of Birmingham and Acticor Biotech announce the First Patient treated in LIBERATE, fir...
GlobeNewswire
07/11/2023
Acticor Biotech has just and timely completed patient recruitment of its phase 2/3 study in stroke
GlobeNewswire
14/09/2023
Acticor adapts its ACTISAVE clinical study to prepare the registration of glenzocimab for the treatm...
GlobeNewswire
15/04/2021
While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inoli...
GlobeNewswire
19/01/2021
Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to advance...
